Journal article
CoMFA analysis of the human β1-adrenoceptor binding affinity of a series of phenoxypropanolamines
SN Louis, LA Rezmann-Vitti, TL Nero, D Iakovidis, GP Jackman, WJ Louis
European Journal of Medicinal Chemistry | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | Published : 2002
Abstract
A series of 36 phenoxypropanolamines was examined to determine the structure-activity relationships of β-adrenoceptor (β-AR) antagonists for the human β1-AR. The binding affinities of all the compounds were determined for human β1-ARs expressed in Chinese hamster ovary cells and the antagonist potency for rat atrial β1-ARs was determined for 32 of these compounds for comparative purposes. The compounds, based upon a phenoxypropanolamine core structure with various meta-, ortho-, para- and amine-substituents, displayed binding affinities (pKi) for the human β1-AR ranging from 5.49 to 9.35. Antagonist potencies (pA2) in the rat ranged from 5.52 to 9.56 and correlated with the human binding aff..
View full abstractGrants
Awarded by National Institute of Mental Health